下肢关节置换加速康复方案:利用观察性数据识别最佳组件组合
该回顾性队列研究利用2006至2016年Premier医疗保健索赔数据,纳入1,539,432例全关节置换术,分析8项加速康复外科(ERAS)组件的常见组合与结局关联。最常见组合为B/D/E/F/G/H(20%)和B/C/D/E/F/G/H(17%),后者仅增加氨甲环酸;对「任何并发症」的降低效应最强组合在2006-2012年为A/B/D/E/F/G/H(OR 0.87),2013-2016年为B/C/D/E/F/G/H(OR 0.86)。
要点
- 最常见ERAS组合从2006-2012年的B/D/E/F/G/H演变为2013-2016年的B/C/D/E/F/G/H,仅增加氨甲环酸。
- 对「任何并发症」降低效应最强:2006-2012年A/B/D/E/F/G/H(OR 0.87,95%CI 0.83-0.91,P<.0001)。
- 2013-2016年B/C/D/E/F/G/H对「任何并发症」OR 0.86(95%CI 0.83-0.89,P<.0001)。
核心结论
- 尽管ERAS方案各异,但在减少并发症方面的最大获益差异很小。
- 需进一步研究ERAS组件数量与增量获益之间的平衡。
研究设计与样本
- 回顾性队列研究,利用Premier Healthcare索赔数据,纳入2006-2016年共1,539,432例全关节置换术。
- 定义8项ERAS组件:A区域麻醉、B多模式镇痛、C氨甲环酸、D手术当日止吐药、E早期物理治疗,以及避免F导尿管、G患者自控镇痛、H引流管。
- 采用混合效应模型评估最常见ERAS组合与结局的关联,报告比值比(OR)和95%置信区间(CI)。
主要发现
- 2006-2012年最常见ERAS组合为B/D/E/F/G/H(20%,n=172,397);2013-2016年为B/C/D/E/F/G/H(17%,n=120,266)。
- 2006-2012年对「任何并发症」效应最强组合为A/B/D/E/F/G/H(占6%),OR 0.87(95%CI 0.83-0.91,P<.0001)。
- 2013-2016年对「任何并发症」效应最强组合为B/C/D/E/F/G/H(占17%),OR 0.86(95%CI 0.83-0.89,P<.0001)。
- 其他结局(住院时间、住院费用)在ERAS方案间差异相对较小。
关键数值与推荐
- 最常见ERAS组合:2006-2012年B/D/E/F/G/H(20%),2013-2016年B/C/D/E/F/G/H(17%)。
- 对「任何并发症」最强效应:2006-2012年A/B/D/E/F/G/H的OR 0.87(95%CI 0.83-0.91,P<.0001)。
- 对「任何并发症」最强效应:2013-2016年B/C/D/E/F/G/H的OR 0.86(95%CI 0.83-0.89,P<.0001)。
临床怎么用
- ERAS方案可包含多模式镇痛、手术当日止吐药、早期物理治疗及避免导尿管、患者自控镇痛和引流管等组件。
- 增加氨甲环酸(C)是近年最常见组合的变化,且与并发症降低相关。
- 组件数量增加与增量获益的平衡需结合进一步研究判断。
局限性
- 回顾性研究设计,基于索赔数据,可能存在混杂和编码偏倚。
- 证据等级为III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enhanced recovery after surgery (ERAS) protocols are increasingly used in orthopedic surgery. Data are lacking on which combinations of ERAS components are (1) the most commonly used and (2) the most effective in terms of outcomes. METHODS: This retrospective cohort study utilized claims data (Premier Healthcare, n = 1,539,432 total joint arthroplasties, 2006-2016). Eight ERAS components were defined: (A) regional anesthesia, (B) multimodal analgesia, (C) tranexamic acid, (D) antiemetics on day of surgery, (E) early physical therapy, and avoidance of (F) urinary catheters, (G) patient-controlled analgesia, and (H) drains. Outcomes were length of stay, "any complication," and hospitalization cost. Mixed-effects models measured associations between the most common ERAS combinations and outcomes. Odds ratios (ORs) and 95% confidence intervals (CIs) are reported. RESULTS: In 2006-2012 and 2013-2016, the most common ERAS combinations were B/D/E/F/G/H (20%, n = 172,397) and B/C/D/E/F/G/H (17%, n = 120,266), respectively. The only difference between the most commonly used ERAS combinations over the years is the addition of C (addition of tranexamic acid to the protocol). The most pronounced beneficial effects in 2006-2012 were seen for combination A/B/D/E/F/G/H (6% of cases vs less prevalent ERAS combinations) for the outcome of "any complication" (OR 0.87, CI 0.83-0.91, P < .0001). In 2013-2016, the strongest effects were seen for combination B/C/D/E/F/G/H (17% of cases) also for the outcome of "any complication" (OR 0.86, CI 0.83-0.89, P < .0001). Relatively minor differences existed between ERAS protocols for the other outcomes. CONCLUSION: Despite varying ERAS protocols, maximum benefits in terms of complication reduction differed minimally. Further study may elucidate the balance between an increasing number of ERAS components and incremental benefits realized. LEVEL OF EVIDENCE: III.
引用
- Chen KK, Chan JJ, Zubizarreta NJ, et al. Enhanced Recovery After Surgery Protocols in Lower Extremity Joint Arthroplasty: Using Observational Data to Identify the Optimal Combination of Components. J Arthroplasty. 2021. PMID: 33757714. doi:10.1016/j.arth.2021.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。